Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Antiviral Agents/*therapeutic use"'
Autor:
Emily D. Meyer, Sandra Dudareva, Christian Kollan, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Ruth Zimmermann
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015. During the COVID-19 pandemic, lockdowns impacted the access to HCV care services and HCV t
Externí odkaz:
https://doaj.org/article/882aabcf7a0349ddad4d6d71c12232a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fátima Falcão, Carla Lopes, Erica Viegas, Rita Perez, Isabel Aldir, Helena Farinha, António Carvalho, Ana Mirco, Susana Marques, Tiago Bana e Costa, Ana Cláudia Miranda, Luís Lebre, Paula Peixe, Cristina Chagas, Kamal Mansinho, José Manuel Correia
Publikováno v:
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 189-194 (2019)
Introduction: In late 2014, Portugal implemented a national program for the treatment of patients with chronic hepatitis C with directacting antiviral agents. This program has made Portugal one of the first European countries to implement a structure
Externí odkaz:
https://doaj.org/article/5039479f3eb4475ba327d65f1999a35d
Autor:
Bárbara Martins Saraiva, Ana Margarida Garcia, Tiago Milheiro Silva, Catarina Gouveia, Maria João Brito
Publikováno v:
Acta Médica Portuguesa, Vol 34, Iss 4 (2021)
Introduction: Coronavirus disease 2019, or COVID-19, in children is usually a mild disease, but severe illness has been reported. Currently, the therapy benefits of antiviral experimental drugs are still uncertain. The main aim of this study is to de
Externí odkaz:
https://doaj.org/article/48f9d1d56eae44bc90e0997b74b88139
Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication
Autor:
Marfil, Sjanene, Märtson, Anne-Grete, Toren-Wielema, Marlous, Leer-Buter, Coretta van, Schölvinck, Elisabeth H, Alffenaar, Jan-Willem C, Touw, Daan J, Sturkenboom, Marieke G G
Publikováno v:
Therapeutic Drug Monitoring, 45(2), 269-272. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic drug monitoring (TDM) results for ganciclovir in 12 different treatment episodes showed large intraindividual and interindividual variabilities in the trough concentration and area under the 24-hour concentration-time curve (AUC24). Despi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e4b6edbe529e8778eaeca58a443f89
https://doi.org/10.1097/ftd.0000000000001050
https://doi.org/10.1097/ftd.0000000000001050
Autor:
National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication
Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report, is a report of a workshop in which experts evaluated whether an antiviral drug against poliovirus would be helpful in the final stages of the global polio eradication
Autor:
Azita H. Talasaz, Parham Sadeghipour, Kasra Mehdizadeh, Niloofar Khoshnam Rad, Behnood Bikdeli, Gregory Y. H. Lip, Job Harenberg
Publikováno v:
Talasaz, A H, Sadeghipour, P, Mehdizadeh, K, Khoshnam Rad, N, Bikdeli, B, Lip, G Y H & Harenberg, J 2023, ' Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19 : Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals ', Thrombosis and Haemostasis, vol. 123, no. 2, pp. 186-191 . https://doi.org/10.1055/a-1956-9641
Data suggest that coronavirus disease 2019 (COVID-19) results in a prothrombotic state leading to arterial and venous thromboses. Vaccination, novel antiviral drugs, and emerging variants have changed the course of the disease in many ways; however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e46a77b0d83248d00b85da6912c6b4f
https://doi.org/10.1055/a-1956-9641
https://doi.org/10.1055/a-1956-9641
Publikováno v:
Infection and Drug Resistance, Vol 2016, Iss Issue 1, Pp 101-117 (2016)
Urbano Sbarigia,1 Tom R Denee,1 Norris G Turner,2 George J Wan,3 Alan Morrison,4 Anna S Kaufman,4 Gary Rice,5 Geoffrey M Dusheiko6,7 1Janssen Pharmaceutica, Beerse, Belgium; 2Johnson & Johnson Health Care Systems, Inc., Titusville, NJ, 3Mallinckrodt
Externí odkaz:
https://doaj.org/article/3cc36ad5cea94659a854ffc36357afe4
Autor:
Märtson, Anne-Grete, Sturkenboom, Marieke G. G., Knoester, Marjolein, van der Werf, Tjip S., Alffenaar, Jan-Willem C., Hope, William, Edwina, Angela E., Burgerhof, Johannes G. M., Berger, Stefan P., de Joode, Anoek, Damman, Kevin, Verschuuren, Erik A. M., Blokzijl, Hans, Bakker, Martijn, Touw, Daan J., rtson, Anne-Grete Mä
Publikováno v:
J Antimicrob Chemother
The Journal of antimicrobial chemotherapy, 77(2), 466-473. Oxford University Press
Journal of Antimicrobial Chemotherapy
The Journal of antimicrobial chemotherapy, 77(2), 466-473. Oxford University Press
Journal of Antimicrobial Chemotherapy
Background Cytomegalovirus (CMV) can cause severe disease, including rejection in transplant recipients. Ganciclovir and its oral prodrug valganciclovir have been used as first-line therapy for CMV disease in transplant recipients. The exposure targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17781224fa85270a0fe6f2f9092b7e50
https://research.rug.nl/en/publications/ff496bd3-560a-4a0f-9710-eec04dcb3adc
https://research.rug.nl/en/publications/ff496bd3-560a-4a0f-9710-eec04dcb3adc